Michael Barbella, Managing Editor06.21.24
Pristine Surgical has recruited Christopher Cleary to its Board of Directors. Cleary recently served as senior vice president of Corporate Development at Medtronic, where he led acquisition and investment strategies, including the landmark $50 billion acquisition of Covidien in 2014.
"We are thrilled to welcome Chris to the Board of Directors. His extensive experience in corporate development and deep knowledge of the healthcare sector will be instrumental to the organization, enhancing our strategic initiatives, and further expanding our platform,” Pristine Surgical Chairman Garth Greimann said. “His leadership and vision will be instrumental in guiding Pristine Surgical through its next phase of growth and innovation."
Chris brings to his new role more than two decades of experience in corporate development, mergers, and acquisitions, having significantly impacted the medical technology industry through his strategic leadership and visionary approach. He also facilitated more than 35 acquisitions, 25 investments, and orchestrated the $6 billion sale of Covidien's medical supply assets to Cardinal Health. His strategic acumen and negotiation skills helped drive Medtronic’s growth and market expansion. Before joining Medtronic, Cleary was the CEO of Alesia Capital Services and prior to that had a significant tenure at GE Capital, where he held various senior leadership roles. His updated LinkedIn profile lists him as CEO of Biomergence Capital LLC.
"I am excited to join the Board of Directors at Pristine Surgical. Their leadership in single-use endoscopy represents a significant advancement in patient care,” Cleary stated. “I am eager to contribute to their mission, continue to build the platform's adoption, and strategize broader opportunities for connected digital devices in the OR to benefit physicians, surgery centers, and patients."
Pristine Surgical is a medical device company with a mission to simplify endoscopy. The company combines 4K single-use, digital arthroscopes with cloud-based software to make minimally invasive visualization more efficient, consistent, and safe. Pristine Surgical offers a subscription business model with transparent pricing and automated inventory management, delivering improved workflow and reduced costs to the endoscopy suite.
"We are thrilled to welcome Chris to the Board of Directors. His extensive experience in corporate development and deep knowledge of the healthcare sector will be instrumental to the organization, enhancing our strategic initiatives, and further expanding our platform,” Pristine Surgical Chairman Garth Greimann said. “His leadership and vision will be instrumental in guiding Pristine Surgical through its next phase of growth and innovation."
Chris brings to his new role more than two decades of experience in corporate development, mergers, and acquisitions, having significantly impacted the medical technology industry through his strategic leadership and visionary approach. He also facilitated more than 35 acquisitions, 25 investments, and orchestrated the $6 billion sale of Covidien's medical supply assets to Cardinal Health. His strategic acumen and negotiation skills helped drive Medtronic’s growth and market expansion. Before joining Medtronic, Cleary was the CEO of Alesia Capital Services and prior to that had a significant tenure at GE Capital, where he held various senior leadership roles. His updated LinkedIn profile lists him as CEO of Biomergence Capital LLC.
"I am excited to join the Board of Directors at Pristine Surgical. Their leadership in single-use endoscopy represents a significant advancement in patient care,” Cleary stated. “I am eager to contribute to their mission, continue to build the platform's adoption, and strategize broader opportunities for connected digital devices in the OR to benefit physicians, surgery centers, and patients."
Pristine Surgical is a medical device company with a mission to simplify endoscopy. The company combines 4K single-use, digital arthroscopes with cloud-based software to make minimally invasive visualization more efficient, consistent, and safe. Pristine Surgical offers a subscription business model with transparent pricing and automated inventory management, delivering improved workflow and reduced costs to the endoscopy suite.